Back to Search
Start Over
Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke.
- Source :
-
Free radical biology & medicine [Free Radic Biol Med] 2013 Dec; Vol. 65, pp. 1012-1022. Date of Electronic Publication: 2013 Sep 07. - Publication Year :
- 2013
-
Abstract
- Disruption of the blood-brain barrier (BBB) and cerebral edema are the major pathogenic mechanisms leading to neurological dysfunction and death after ischemic stroke. The brain protects itself against infarction via activation of endogenous antioxidant defense mechanisms, and we here report the first evidence that sulforaphane-mediated preactivation of nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream target heme oxygenase-1 (HO-1) in the cerebral vasculature protects the brain against stroke. To induce ischemic stroke, Sprague-Dawley rats were subjected to 70 min middle cerebral artery occlusion (MCAo) followed by 4, 24, or 72 h reperfusion. Nrf2 and HO-1 protein expression was upregulated in cerebral microvessels of peri-infarct regions after 4-72 h, with HO-1 preferentially associated with perivascular astrocytes rather than the cerebrovascular endothelium. In naïve rats, treatment with sulforaphane increased Nrf2 expression in cerebral microvessels after 24h. Upregulation of Nrf2 by sulforaphane treatment prior to transient MCAo (1h) was associated with increased HO-1 expression in perivascular astrocytes in peri-infarct regions and cerebral endothelium in the infarct core. BBB disruption, lesion progression, as analyzed by MRI, and neurological deficits were reduced by sulforaphane pretreatment. As sulforaphane pretreatment led to a moderate increase in peroxynitrite generation, we suggest that hormetic preconditioning underlies sulforaphane-mediated protection against stroke. In conclusion, we propose that pharmacological or dietary interventions aimed to precondition the brain via activation of the Nrf2 defense pathway in the cerebral microvasculature provide a novel therapeutic approach for preventing BBB breakdown and neurological dysfunction in stroke.<br /> (Crown Copyright © 2013. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Blood-Brain Barrier drug effects
Blood-Brain Barrier pathology
Cerebral Arteries drug effects
Cerebral Arteries enzymology
Gene Expression
Heme Oxygenase-1 genetics
Infarction, Middle Cerebral Artery drug therapy
Isothiocyanates therapeutic use
Male
Membrane Proteins genetics
Microvessels enzymology
NF-E2-Related Factor 2 genetics
Neuroprotective Agents therapeutic use
Oxidative Stress
Psychomotor Disorders metabolism
Rats, Sprague-Dawley
Reperfusion Injury metabolism
Reperfusion Injury prevention & control
Signal Transduction
Sulfoxides
Up-Regulation
Blood-Brain Barrier metabolism
Heme Oxygenase-1 metabolism
Infarction, Middle Cerebral Artery metabolism
Isothiocyanates pharmacology
Membrane Proteins metabolism
NF-E2-Related Factor 2 metabolism
Neuroprotective Agents pharmacology
Psychomotor Disorders prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1873-4596
- Volume :
- 65
- Database :
- MEDLINE
- Journal :
- Free radical biology & medicine
- Publication Type :
- Academic Journal
- Accession number :
- 24017972
- Full Text :
- https://doi.org/10.1016/j.freeradbiomed.2013.08.190